Global Primary Ciliary Dyskinesia Market 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	193 Pages	TechNavio	August, 2024	INF19384990

Best Price Guarantee
Price	from $2,500
Length	193 Pages
Publisher	TechNavio
Published Date	August, 2024
SKU	INF19384990

Global Primary Ciliary Dyskinesia Market 2024-2028

Global Primary Ciliary Dyskinesia Market 2024-2028

The primary ciliary dyskinesia market is forecasted to grow by USD 160.2 mn during 2023-2028, accelerating at a CAGR of 5.7% during the forecast period. The report on the primary ciliary dyskinesia market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing awareness of PCD conditions, improving healthcare infrastructure, and increase in funding for research activities.

Technavio's primary ciliary dyskinesia market is segmented as below:

By Type
Genetic testing
Electron microscopy
Nasal nitric Oxide (NnO) testing
By Application
Hospitals
Speciality clinics
Research centers
By Geographical Landscape
Europe
North America
Asia
Rest of World (ROW)

This study identifies the increasing pipeline projects on PCD as one of the prime reasons driving the primary ciliary dyskinesia market growth during the next few years. Also, the increasing focus on global accessibility of PCD treatments and technological innovations in treatment of PCD will lead to sizable demand in the market.

The report on the primary ciliary dyskinesia market covers the following areas:

Primary ciliary dyskinesia market sizing
Primary ciliary dyskinesia market forecast
Primary ciliary dyskinesia market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading primary ciliary dyskinesia market vendors that include Acare Technology Co. Ltd., Amgen Inc., AstraZeneca PLC, Bayer AG, Becton Dickinson and Co., Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., CHIESI Farmaceutici SpA, F. Hoffmann La Roche Ltd., Fitwel Pharmaceuticals Pvt. Ltd., Gilead Sciences Inc., GlaxoSmithKline PLC, Medigene AG, Novartis AG, Pfizer Inc., ReCode Therapeutics, Regeneron Pharmaceuticals Inc., Rotech Healthcare Inc., Sanofi SA, and Teva UK Ltd.. Also, the primary ciliary dyskinesia market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Global Market Characteristics; Executive Summary - Chart on Market By Geographical Landscape; Executive Summary - Chart on Market Segmentation by Type; Executive Summary - Chart on Market Segmentation by Application; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis: 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; 2.2 Criticality of inputs and Factors of differentiation; Overview on criticality of inputs and factors of differentiation; 2.3 Factors of disruption; Overview on factors of disruption; 2.4 Impact of drivers and challenges; Impact of drivers and challenges in 2023 and 2028
3 Market Landscape: 3.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 3.2 Market characteristics; Market characteristics analysis; 3.3 Value chain analysis; Value Chain Analysis
4 Market Sizing: 4.1 Market definition; Offerings of companies included in the market definition; 4.2 Market segment analysis; Market segments; 4.3 Market size 2023; 4.4 Market outlook: Forecast for 2023-2028; Chart on Global - Market size and forecast 2023-2028 ($ million); Data Table on Global - Market size and forecast 2023-2028 ($ million); Chart on Global Market: Year-over-year growth 2023-2028 (%); Data Table on Global Market: Year-over-year growth 2023-2028 (%)
5 Historic Market Size: 5.1 Global Primary Ciliary Dyskinesia Market 2018 - 2022; Historic Market Size - Data Table on Global Primary Ciliary Dyskinesia Market 2018 - 2022 ($ million); 5.2 Type segment analysis 2018 - 2022; Historic Market Size - Type Segment 2018 - 2022 ($ million); 5.3 Application segment analysis 2018 - 2022; Historic Market Size - Application Segment 2018 - 2022 ($ million); 5.4 Geography segment analysis 2018 - 2022; Historic Market Size - Geography Segment 2018 - 2022 ($ million); 5.5 Country segment analysis 2018 - 2022; Historic Market Size - Country Segment 2018 - 2022 ($ million)
6 Additional Value/Volume Data: 6.1 Global Primary ciliary dyskinesia market by country 2023 - 2028 ($ billion); Market Size (value) - Data Table on Global Primary ciliary dyskinesia market by Country 2023 - 2028 ($ billion)
7 Five Forces Analysis: 7.1 Five forces summary; Five forces analysis - Comparison between 2023 and 2028; 7.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2023 and 2028; 7.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 7.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2023 and 2028; 7.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2023 and 2028; 7.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2023 and 2028; 7.7 Market condition; Chart on Market condition - Five forces 2023 and 2028
8 Market Segmentation by Type: 8.1 Market segments; Chart on Type - Market share 2023-2028 (%); Data Table on Type - Market share 2023-2028 (%); 8.2 Comparison by Type; Chart on Comparison by Type; Data Table on Comparison by Type; 8.3 Genetic testing - Market size and forecast 2023-2028; Chart on Genetic testing - Market size and forecast 2023-2028 ($ million); Data Table on Genetic testing - Market size and forecast 2023-2028 ($ million); Chart on Genetic testing - Year-over-year growth 2023-2028 (%); Data Table on Genetic testing - Year-over-year growth 2023-2028 (%); 8.4 Electron microscopy - Market size and forecast 2023-2028; Chart on Electron microscopy - Market size and forecast 2023-2028 ($ million); Data Table on Electron microscopy - Market size and forecast 2023-2028 ($ million); Chart on Electron microscopy - Year-over-year growth 2023-2028 (%); Data Table on Electron microscopy - Year-over-year growth 2023-2028 (%); 8.5 Nasal nitric Oxide (Nno) testing - Market size and forecast 2023-2028; Chart on Nasal nitric Oxide (Nno) testing - Market size and forecast 2023-2028 ($ million); Data Table on Nasal nitric Oxide (Nno) testing - Market size and forecast 2023-2028 ($ million); Chart on Nasal nitric Oxide (Nno) testing - Year-over-year growth 2023-2028 (%); Data Table on Nasal nitric Oxide (Nno) testing - Year-over-year growth 2023-2028 (%); 8.6 Market opportunity by Type; Market opportunity by Type ($ million); Data Table on Market opportunity by Type ($ million)
9 Market Segmentation by Application: 9.1 Market segments; Chart on Application - Market share 2023-2028 (%); Data Table on Application - Market share 2023-2028 (%); 9.2 Comparison by Application; Chart on Comparison by Application; Data Table on Comparison by Application; 9.3 Hospitals - Market size and forecast 2023-2028; Chart on Hospitals - Market size and forecast 2023-2028 ($ million); Data Table on Hospitals - Market size and forecast 2023-2028 ($ million); Chart on Hospitals - Year-over-year growth 2023-2028 (%); Data Table on Hospitals - Year-over-year growth 2023-2028 (%); 9.4 Speciality clinics - Market size and forecast 2023-2028; Chart on Speciality clinics - Market size and forecast 2023-2028 ($ million); Data Table on Speciality clinics - Market size and forecast 2023-2028 ($ million); Chart on Speciality clinics - Year-over-year growth 2023-2028 (%); Data Table on Speciality clinics - Year-over-year growth 2023-2028 (%); 9.5 Research centers - Market size and forecast 2023-2028; Chart on Research centers - Market size and forecast 2023-2028 ($ million); Data Table on Research centers - Market size and forecast 2023-2028 ($ million); Chart on Research centers - Year-over-year growth 2023-2028 (%); Data Table on Research centers - Year-over-year growth 2023-2028 (%); 9.6 Market opportunity by Application; Market opportunity by Application ($ million); Data Table on Market opportunity by Application ($ million)
10 Customer Landscape: 10.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
11 Geographic Landscape: 11.1 Geographic segmentation; Chart on Market share By Geographical Landscape 2023-2028 (%); Data Table on Market share By Geographical Landscape 2023-2028 (%); 11.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 11.3 Europe - Market size and forecast 2023-2028; Chart on Europe - Market size and forecast 2023-2028 ($ million); Data Table on Europe - Market size and forecast 2023-2028 ($ million); Chart on Europe - Year-over-year growth 2023-2028 (%); Data Table on Europe - Year-over-year growth 2023-2028 (%); 11.4 North America - Market size and forecast 2023-2028; Chart on North America - Market size and forecast 2023-2028 ($ million); Data Table on North America - Market size and forecast 2023-2028 ($ million); Chart on North America - Year-over-year growth 2023-2028 (%); Data Table on North America - Year-over-year growth 2023-2028 (%); 11.5 Asia - Market size and forecast 2023-2028; Chart on Asia - Market size and forecast 2023-2028 ($ million); Data Table on Asia - Market size and forecast 2023-2028 ($ million); Chart on Asia - Year-over-year growth 2023-2028 (%); Data Table on Asia - Year-over-year growth 2023-2028 (%); 11.6 Rest of World (ROW) - Market size and forecast 2023-2028; Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); 11.7 US - Market size and forecast 2023-2028; Chart on US - Market size and forecast 2023-2028 ($ million); Data Table on US - Market size and forecast 2023-2028 ($ million); Chart on US - Year-over-year growth 2023-2028 (%); Data Table on US - Year-over-year growth 2023-2028 (%); 11.8 UK - Market size and forecast 2023-2028; Chart on UK - Market size and forecast 2023-2028 ($ million); Data Table on UK - Market size and forecast 2023-2028 ($ million); Chart on UK - Year-over-year growth 2023-2028 (%); Data Table on UK - Year-over-year growth 2023-2028 (%); 11.9 Canada - Market size and forecast 2023-2028; Chart on Canada - Market size and forecast 2023-2028 ($ million); Data Table on Canada - Market size and forecast 2023-2028 ($ million); Chart on Canada - Year-over-year growth 2023-2028 (%); Data Table on Canada - Year-over-year growth 2023-2028 (%); 11.10 Germany - Market size and forecast 2023-2028; Chart on Germany - Market size and forecast 2023-2028 ($ million); Data Table on Germany - Market size and forecast 2023-2028 ($ million); Chart on Germany - Year-over-year growth 2023-2028 (%); Data Table on Germany - Year-over-year growth 2023-2028 (%); 11.11 Japan - Market size and forecast 2023-2028; Chart on Japan - Market size and forecast 2023-2028 ($ million); Data Table on Japan - Market size and forecast 2023-2028 ($ million); Chart on Japan - Year-over-year growth 2023-2028 (%); Data Table on Japan - Year-over-year growth 2023-2028 (%); 11.12 Switzerland - Market size and forecast 2023-2028; Chart on Switzerland - Market size and forecast 2023-2028 ($ million); Data Table on Switzerland - Market size and forecast 2023-2028 ($ million); Chart on Switzerland - Year-over-year growth 2023-2028 (%); Data Table on Switzerland - Year-over-year growth 2023-2028 (%); 11.13 Market opportunity By Geographical Landscape; Market opportunity By Geographical Landscape ($ million); Data Tables on Market opportunity By Geographical Landscape ($ million)
12 Drivers, Challenges, and Opportunity/Restraints: 12.1 Market drivers; 12.2 Market challenges; 12.3 Impact of drivers and challenges; Impact of drivers and challenges in 2023 and 2028; 12.4 Market opportunities/restraints
13 Competitive Landscape: 13.1 Overview; 13.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 13.3 Landscape disruption; Overview on factors of disruption; 13.4 Industry risks; Impact of key risks on business
14 Competitive Analysis: 14.1 Companies profiled; Companies covered; 14.2 Company ranking index; Company ranking index; 14.3 Market positioning of companies; Matrix on companies position and classification; 14.4 Acare Technology Co. Ltd.; Acare Technology Co. Ltd. - Overview; Acare Technology Co. Ltd. - Product / Service; Acare Technology Co. Ltd. - Key offerings; SWOT; 14.5 AstraZeneca Plc; AstraZeneca Plc - Overview; AstraZeneca Plc - Product / Service; AstraZeneca Plc - Key news; AstraZeneca Plc - Key offerings; SWOT; 14.6 Bayer AG; Bayer AG - Overview; Bayer AG - Business segments; Bayer AG - Key news; Bayer AG - Key offerings; Bayer AG - Segment focus; SWOT; 14.7 Boehringer Ingelheim International GmbH; Boehringer Ingelheim International GmbH - Overview; Boehringer Ingelheim International GmbH - Product / Service; Boehringer Ingelheim International GmbH - Key news; Boehringer Ingelheim International GmbH - Key offerings; SWOT; 14.8 CHIESI Farmaceutici SpA; CHIESI Farmaceutici SpA - Overview; CHIESI Farmaceutici SpA - Product / Service; CHIESI Farmaceutici SpA - Key offerings; SWOT; 14.9 Fitwel Pharmaceuticals Pvt. Ltd.; Fitwel Pharmaceuticals Pvt. Ltd. - Overview; Fitwel Pharmaceuticals Pvt. Ltd. - Product / Service; Fitwel Pharmaceuticals Pvt. Ltd. - Key offerings; SWOT; 14.10 GlaxoSmithKline Plc; GlaxoSmithKline Plc - Overview; GlaxoSmithKline Plc - Business segments; GlaxoSmithKline Plc - Key news; GlaxoSmithKline Plc - Key offerings; GlaxoSmithKline Plc - Segment focus; SWOT; 14.11 Medigene AG; Medigene AG - Overview; Medigene AG - Product / Service; Medigene AG - Key offerings; SWOT; 14.12 Novartis AG; Novartis AG - Overview; Novartis AG - Business segments; Novartis AG - Key news; Novartis AG - Key offerings; Novartis AG - Segment focus; SWOT; 14.13 Pfizer Inc.; Pfizer Inc. - Overview; Pfizer Inc. - Product / Service; Pfizer Inc. - Key news; Pfizer Inc. - Key offerings; SWOT; 14.14 ReCode Therapeutics; ReCode Therapeutics - Overview; ReCode Therapeutics - Product / Service; ReCode Therapeutics - Key offerings; SWOT; 14.15 Regeneron Pharmaceuticals Inc.; Regeneron Pharmaceuticals Inc. - Overview; Regeneron Pharmaceuticals Inc. - Product / Service; Regeneron Pharmaceuticals Inc. - Key offerings; SWOT; 14.16 Rotech Healthcare Inc.; Rotech Healthcare Inc. - Overview; Rotech Healthcare Inc. - Key offerings; SWOT; 14.17 Sanofi SA; Sanofi SA - Overview; Sanofi SA - Business segments; Sanofi SA - Key news; Sanofi SA - Key offerings; Sanofi SA - Segment focus; SWOT; 14.18 Teva UK Ltd.; Teva UK Ltd. - Overview; Teva UK Ltd. - Product / Service; Teva UK Ltd. - Key offerings; SWOT
15 Appendix: 15.1 Scope of the report; 15.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 15.3 Currency conversion rates for US$; Currency conversion rates for US$; 15.4 Research methodology; Research methodology; 15.5 Data procurement; Information sources; 15.6 Data validation; Data validation; 15.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 15.8 Data synthesis; Data synthesis; 15.9 360 degree market analysis; 360 degree market analysis; 15.10 List of abbreviations; List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by Type; Exhibits6: Executive Summary - Chart on Market Segmentation by Application; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Company Market Positioning; Exhibits10: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits11: Overview on criticality of inputs and factors of differentiation; Exhibits12: Overview on factors of disruption; Exhibits13: Impact of drivers and challenges in 2023 and 2028; Exhibits14: Parent Market; Exhibits15: Data Table on - Parent Market; Exhibits16: Market characteristics analysis; Exhibits17: Value Chain Analysis; Exhibits18: Offerings of companies included in the market definition; Exhibits19: Market segments; Exhibits20: Chart on Global - Market size and forecast 2023-2028 ($ million); Exhibits21: Data Table on Global - Market size and forecast 2023-2028 ($ million); Exhibits22: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibits23: Data Table on Global Market: Year-over-year growth 2023-2028 (%); Exhibits24: Historic Market Size - Data Table on Global Primary Ciliary Dyskinesia Market 2018 - 2022 ($ million); Exhibits25: Historic Market Size - Type Segment 2018 - 2022 ($ million); Exhibits26: Historic Market Size - Application Segment 2018 - 2022 ($ million); Exhibits27: Historic Market Size - Geography Segment 2018 - 2022 ($ million); Exhibits28: Historic Market Size - Country Segment 2018 - 2022 ($ million); Exhibits29: Market Size (value) - Data Table on Global Primary ciliary dyskinesia market by Country 2023 - 2028 ($ billion); Exhibits30: Five forces analysis - Comparison between 2023 and 2028; Exhibits31: Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits32: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits33: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits34: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits35: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits36: Chart on Market condition - Five forces 2023 and 2028; Exhibits37: Chart on Type - Market share 2023-2028 (%); Exhibits38: Data Table on Type - Market share 2023-2028 (%); Exhibits39: Chart on Comparison by Type; Exhibits40: Data Table on Comparison by Type; Exhibits41: Chart on Genetic testing - Market size and forecast 2023-2028 ($ million); Exhibits42: Data Table on Genetic testing - Market size and forecast 2023-2028 ($ million); Exhibits43: Chart on Genetic testing - Year-over-year growth 2023-2028 (%); Exhibits44: Data Table on Genetic testing - Year-over-year growth 2023-2028 (%); Exhibits45: Chart on Electron microscopy - Market size and forecast 2023-2028 ($ million); Exhibits46: Data Table on Electron microscopy - Market size and forecast 2023-2028 ($ million); Exhibits47: Chart on Electron microscopy - Year-over-year growth 2023-2028 (%); Exhibits48: Data Table on Electron microscopy - Year-over-year growth 2023-2028 (%); Exhibits49: Chart on Nasal nitric Oxide (Nno) testing - Market size and forecast 2023-2028 ($ million); Exhibits50: Data Table on Nasal nitric Oxide (Nno) testing - Market size and forecast 2023-2028 ($ million); Exhibits51: Chart on Nasal nitric Oxide (Nno) testing - Year-over-year growth 2023-2028 (%); Exhibits52: Data Table on Nasal nitric Oxide (Nno) testing - Year-over-year growth 2023-2028 (%); Exhibits53: Market opportunity by Type ($ million); Exhibits54: Data Table on Market opportunity by Type ($ million); Exhibits55: Chart on Application - Market share 2023-2028 (%); Exhibits56: Data Table on Application - Market share 2023-2028 (%); Exhibits57: Chart on Comparison by Application; Exhibits58: Data Table on Comparison by Application; Exhibits59: Chart on Hospitals - Market size and forecast 2023-2028 ($ million); Exhibits60: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million); Exhibits61: Chart on Hospitals - Year-over-year growth 2023-2028 (%); Exhibits62: Data Table on Hospitals - Year-over-year growth 2023-2028 (%); Exhibits63: Chart on Speciality clinics - Market size and forecast 2023-2028 ($ million); Exhibits64: Data Table on Speciality clinics - Market size and forecast 2023-2028 ($ million); Exhibits65: Chart on Speciality clinics - Year-over-year growth 2023-2028 (%); Exhibits66: Data Table on Speciality clinics - Year-over-year growth 2023-2028 (%); Exhibits67: Chart on Research centers - Market size and forecast 2023-2028 ($ million); Exhibits68: Data Table on Research centers - Market size and forecast 2023-2028 ($ million); Exhibits69: Chart on Research centers - Year-over-year growth 2023-2028 (%); Exhibits70: Data Table on Research centers - Year-over-year growth 2023-2028 (%); Exhibits71: Market opportunity by Application ($ million); Exhibits72: Data Table on Market opportunity by Application ($ million); Exhibits73: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits74: Chart on Market share By Geographical Landscape 2023-2028 (%); Exhibits75: Data Table on Market share By Geographical Landscape 2023-2028 (%); Exhibits76: Chart on Geographic comparison; Exhibits77: Data Table on Geographic comparison; Exhibits78: Chart on Europe - Market size and forecast 2023-2028 ($ million); Exhibits79: Data Table on Europe - Market size and forecast 2023-2028 ($ million); Exhibits80: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibits81: Data Table on Europe - Year-over-year growth 2023-2028 (%); Exhibits82: Chart on North America - Market size and forecast 2023-2028 ($ million); Exhibits83: Data Table on North America - Market size and forecast 2023-2028 ($ million); Exhibits84: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibits85: Data Table on North America - Year-over-year growth 2023-2028 (%); Exhibits86: Chart on Asia - Market size and forecast 2023-2028 ($ million); Exhibits87: Data Table on Asia - Market size and forecast 2023-2028 ($ million); Exhibits88: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibits89: Data Table on Asia - Year-over-year growth 2023-2028 (%); Exhibits90: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits91: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits92: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits93: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits94: Chart on US - Market size and forecast 2023-2028 ($ million); Exhibits95: Data Table on US - Market size and forecast 2023-2028 ($ million); Exhibits96: Chart on US - Year-over-year growth 2023-2028 (%); Exhibits97: Data Table on US - Year-over-year growth 2023-2028 (%); Exhibits98: Chart on UK - Market size and forecast 2023-2028 ($ million); Exhibits99: Data Table on UK - Market size and forecast 2023-2028 ($ million); Exhibits100: Chart on UK - Year-over-year growth 2023-2028 (%); Exhibits101: Data Table on UK - Year-over-year growth 2023-2028 (%); Exhibits102: Chart on Canada - Market size and forecast 2023-2028 ($ million); Exhibits103: Data Table on Canada - Market size and forecast 2023-2028 ($ million); Exhibits104: Chart on Canada - Year-over-year growth 2023-2028 (%); Exhibits105: Data Table on Canada - Year-over-year growth 2023-2028 (%); Exhibits106: Chart on Germany - Market size and forecast 2023-2028 ($ million); Exhibits107: Data Table on Germany - Market size and forecast 2023-2028 ($ million); Exhibits108: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibits109: Data Table on Germany - Year-over-year growth 2023-2028 (%); Exhibits110: Chart on Japan - Market size and forecast 2023-2028 ($ million); Exhibits111: Data Table on Japan - Market size and forecast 2023-2028 ($ million); Exhibits112: Chart on Japan - Year-over-year growth 2023-2028 (%); Exhibits113: Data Table on Japan - Year-over-year growth 2023-2028 (%); Exhibits114: Chart on Switzerland - Market size and forecast 2023-2028 ($ million); Exhibits115: Data Table on Switzerland - Market size and forecast 2023-2028 ($ million); Exhibits116: Chart on Switzerland - Year-over-year growth 2023-2028 (%); Exhibits117: Data Table on Switzerland - Year-over-year growth 2023-2028 (%); Exhibits118: Market opportunity By Geographical Landscape ($ million); Exhibits119: Data Tables on Market opportunity By Geographical Landscape ($ million); Exhibits120: Impact of drivers and challenges in 2023 and 2028; Exhibits121: Overview on criticality of inputs and factors of differentiation; Exhibits122: Overview on factors of disruption; Exhibits123: Impact of key risks on business; Exhibits124: Companies covered; Exhibits125: Company ranking index; Exhibits126: Matrix on companies position and classification; Exhibits127: Acare Technology Co. Ltd. - Overview; Exhibits128: Acare Technology Co. Ltd. - Product / Service; Exhibits129: Acare Technology Co. Ltd. - Key offerings; Exhibits130: SWOT; Exhibits131: AstraZeneca Plc - Overview; Exhibits132: AstraZeneca Plc - Product / Service; Exhibits133: AstraZeneca Plc - Key news; Exhibits134: AstraZeneca Plc - Key offerings; Exhibits135: SWOT; Exhibits136: Bayer AG - Overview; Exhibits137: Bayer AG - Business segments; Exhibits138: Bayer AG - Key news; Exhibits139: Bayer AG - Key offerings; Exhibits140: Bayer AG - Segment focus; Exhibits141: SWOT; Exhibits142: Boehringer Ingelheim International GmbH - Overview; Exhibits143: Boehringer Ingelheim International GmbH - Product / Service; Exhibits144: Boehringer Ingelheim International GmbH - Key news; Exhibits145: Boehringer Ingelheim International GmbH - Key offerings; Exhibits146: SWOT; Exhibits147: CHIESI Farmaceutici SpA - Overview; Exhibits148: CHIESI Farmaceutici SpA - Product / Service; Exhibits149: CHIESI Farmaceutici SpA - Key offerings; Exhibits150: SWOT; Exhibits151: Fitwel Pharmaceuticals Pvt. Ltd. - Overview; Exhibits152: Fitwel Pharmaceuticals Pvt. Ltd. - Product / Service; Exhibits153: Fitwel Pharmaceuticals Pvt. Ltd. - Key offerings; Exhibits154: SWOT; Exhibits155: GlaxoSmithKline Plc - Overview; Exhibits156: GlaxoSmithKline Plc - Business segments; Exhibits157: GlaxoSmithKline Plc - Key news; Exhibits158: GlaxoSmithKline Plc - Key offerings; Exhibits159: GlaxoSmithKline Plc - Segment focus; Exhibits160: SWOT; Exhibits161: Medigene AG - Overview; Exhibits162: Medigene AG - Product / Service; Exhibits163: Medigene AG - Key offerings; Exhibits164: SWOT; Exhibits165: Novartis AG - Overview; Exhibits166: Novartis AG - Business segments; Exhibits167: Novartis AG - Key news; Exhibits168: Novartis AG - Key offerings; Exhibits169: Novartis AG - Segment focus; Exhibits170: SWOT; Exhibits171: Pfizer Inc. - Overview; Exhibits172: Pfizer Inc. - Product / Service; Exhibits173: Pfizer Inc. - Key news; Exhibits174: Pfizer Inc. - Key offerings; Exhibits175: SWOT; Exhibits176: ReCode Therapeutics - Overview; Exhibits177: ReCode Therapeutics - Product / Service; Exhibits178: ReCode Therapeutics - Key offerings; Exhibits179: SWOT; Exhibits180: Regeneron Pharmaceuticals Inc. - Overview; Exhibits181: Regeneron Pharmaceuticals Inc. - Product / Service; Exhibits182: Regeneron Pharmaceuticals Inc. - Key offerings; Exhibits183: SWOT; Exhibits184: Rotech Healthcare Inc. - Overview; Exhibits185: Rotech Healthcare Inc. - Key offerings; Exhibits186: SWOT; Exhibits187: Sanofi SA - Overview; Exhibits188: Sanofi SA - Business segments; Exhibits189: Sanofi SA - Key news; Exhibits190: Sanofi SA - Key offerings; Exhibits191: Sanofi SA - Segment focus; Exhibits192: SWOT; Exhibits193: Teva UK Ltd. - Overview; Exhibits194: Teva UK Ltd. - Product / Service; Exhibits195: Teva UK Ltd. - Key offerings; Exhibits196: SWOT; Exhibits197: Inclusions checklist; Exhibits198: Exclusions checklist; Exhibits199: Currency conversion rates for US$; Exhibits200: Research methodology; Exhibits201: Information sources; Exhibits202: Data validation; Exhibits203: Validation techniques employed for market sizing; Exhibits204: Data synthesis; Exhibits205: 360 degree market analysis; Exhibits206: List of abbreviations